

Korean pharmaceutical company wins tender for supply of anti-cancer drugs to Turkmenistan
The South Korean pharmaceutical company Celltrion Healthcare won a tender for a contract with UNDP to supply anti-cancer drugs to Turkmenistan. These drugs include Truxima (for the treatment of blood cancer) and Vegzelma (for the treatment of metastatic colorectal and breast cancer), which will be delivered before the end of this year, Financial News reports.



















